-
WZ4003: A Mechanism-First NUAK Assay Guide
2026-08-15
WZ4003 is a selective NUAK1/2 inhibitor for connecting kinase engagement with migration, cell-cycle, invasion, and tau biology. This guide presents an assay-centered framework for interpreting its effects across cancer research and neurodegeneration models while distinguishing target-specific activity from tissue-level toxicity.
-
I-BET-762 for Reliable Cell Viability Assays
2026-08-14
This scenario-based guide explains how I-BET-762, SKU B1498, can support controlled viability, proliferation, and cytotoxicity workflows involving BET-dependent transcription and ferroptosis. It connects product formulation data with published evidence while emphasizing controls, dosing, storage, and interpretation limits.
-
Thiamet G: O-GlcNAc as a Translational Lever
2026-08-14
A mechanistic and strategic guide to using Thiamet G as a reversible O-GlcNAcase inhibitor across bone biology, neurodegeneration, and oncology research.
-
Exendin-4: Reliable Cell Assay Workflows
2026-08-13
This scenario-based guide explains how Exendin-4 and SKU A3408 can support more interpretable beta-cell, insulin-secretion, and cytotoxicity workflows. It covers concentration selection, solvent compatibility, storage, data interpretation, and practical vendor evaluation for type 2 diabetes research.
-
AEBSF.HCl and the Protease Logic of Necroptosis
2026-08-13
A mechanistic and translational framework for using AEBSF.HCl to interrogate serine protease biology alongside MLKL-driven lysosomal membrane permeabilization, amyloid precursor protein processing, and immune-mediated cytotoxicity.
-
Cucurbitacin I: Context-Aware STAT3 Assays
2026-08-12
Cucurbitacin I (JSI-124) is a selective JAK2/STAT3-pathway inhibitor for mechanistic cancer studies. This guide adds a context-aware assay framework inspired by human neuro-cardiac assembloids, helping researchers connect molecular STAT3 readouts with invasion, apoptosis, and tumor phenotypes without overinterpreting model-specific results.
-
Amyloid Beta-Peptide (1-40) (human) Guide
2026-08-12
A scenario-driven guide to using Amyloid Beta-Peptide (1-40) (human), SKU A1124, in cell viability, proliferation, and neurotoxicity workflows. It connects peptide handling, aggregation-state control, assay interpretation, and vendor selection with current evidence on Aβ monomer biology.
-
SN-38, FUBP1, and FUSE: A Mechanistic Study
2026-08-11
The 2017 Biochemical Pharmacology study identified an activity of camptothecin and SN-38 beyond canonical topoisomerase I poisoning: inhibition of FUBP1 binding to the single-stranded FUSE regulatory element. Its screening, biochemical, and hepatocellular carcinoma experiments suggest that disrupted FUBP1 transcriptional control may contribute to the antitumor effects of SN-38, while also defining important limits for extrapolation to other cancer models.
-
N-MYC–eIF4G1 Signaling in inv(16) AML
2026-08-11
This Science Advances study identifies an MYCN enhancer and the translation factor eIF4G1 as components of a survival pathway in inv(16) acute myeloid leukemia. By integrating transcriptomic analysis, leukemia models, and functional perturbation, the work establishes an N-MYC/eIF4G1 axis that may help explain disease maintenance and guide mechanism-focused AML research.
-
HyperPFU™ high-fidelity DNA polymerase Guide
2026-08-10
HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is suited to blunt-ended products for cloning and sequencing, but it should not be selected when 3′-A overhangs or sticky-end products are required.
-
Ferrocenyl Novobiocin Derivatives: Study Insights
2026-08-09
The 2017 study developed matched organic and ferrocenyl novobiocin derivatives and evaluated them against Plasmodium falciparum 3D7 and HCC38 breast cancer cells. Its central finding was that incorporating ferrocene generally improved in vitro activity, supporting bioorganometallic modification as a strategy for expanding the novobiocin scaffold while highlighting the need for deeper selectivity and mechanism studies.
-
Adult Stem Cells Methods: Regenerative Research
2026-08-08
Adult Stem Cells Methods and Protocols, Second Edition, presents a reproducibility-focused framework for isolating, characterizing, engineering, and transplanting adult stem cells. Its central contribution is methodological: regenerative outcomes depend on integrating cell biology with scaffold design, viability assessment, and tissue-specific validation rather than treating stem cell isolation as a standalone solution.
-
Naloxone Hydrochloride: Research Workflows
2026-08-07
Discover how naloxone hydrochloride can anchor receptor pharmacology, opioid addiction and withdrawal studies, neural stem cell assays, and immune-function experiments. This workflow-focused guide combines reference-study insights with practical preparation, controls, and troubleshooting strategies.
-
Docosahexaenoic Acid in Neuroprotection: Protocols & Innovat
2026-08-07
Docosahexaenoic Acid (DHA) is an essential experimental tool for modeling neuroprotection, anti-inflammatory responses, and lipid homeostasis in both in vitro and in vivo systems. This guide translates the latest spatial metabolomics breakthroughs into actionable workflows, troubleshooting strategies, and advanced applications using high-purity DHA from APExBIO.
-
GSK621 (SKU B6020): Reliable AMPK Agonist for Assay Consiste
2026-08-06
This in-depth article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, offering scenario-driven guidance on using GSK621 (SKU B6020) as a potent and specific AMPK agonist. Drawing from peer-reviewed studies and validated protocols, we demonstrate how GSK621 enhances reproducibility, sensitivity, and workflow efficiency for metabolic research.